NCT07180134Not yet recruiting
Health Informatics and Resistance Exercise for Symptom Management and Quality of Life in Post-Esophagectomy Patients
Effects of Health Informatics for Symptom Management and Resistance Exercise Strategies on Quality of Life and Sarcopenia in Post-Esophagectomy Patients With Esophageal Cancer: A Mixed-Methods Study
Source: ClinicalTrials.gov · Last updated 18 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Participants are invited to take part in a research study. In accordance with the requirements of the health authorities, participants must be informed of the purpose of the study and its potential risks. Participation is voluntary, and each participant is free to decide whether or not to enroll. The study may be discussed with trusted individuals, and sufficient time may be taken to consider the decision. If any part of this consent form is unclear, questions may be directed to the principal investigator or the research team, who will provide an explanation. If a participant chooses not to participate, appropriate treatment will still be provided. Even if a participant agrees to participate initially, withdrawal is allowed at any time without affecting medical rights or the care that should be received.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- First submitted
- 19 Aug 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 31 Jul 2027
- Lead sponsor
- Chang Gung Memorial Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT07180134
What you commit to
- Study type: Interventional
- Planned participants: 90
- From 1 Oct 2025 to the primary completion date, 31 Jul 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of severe cardiovascular disease or psychiatric disorders
- Disease progression during the intervention period that prevents continuation of participation.
Other
- Inability to communicate in Mandarin Chinese or Taiwanese
Who the study is looking for
- Age 18 years or older
- Diagnosed with esophageal cancer and having undergone esophagectomy
- Postoperative pathological report confirms R0 resection (complete tumor removal)
- Able to be discharged after surgery
- With or without adjuvant chemoradiotherapy
- Clear consciousness and able to communicate in Mandarin or Taiwanese
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.